Free Trial

Intuitive Surgical (ISRG) Competitors

Intuitive Surgical logo
$541.82 +3.00 (+0.56%)
(As of 11/20/2024 ET)

ISRG vs. ABT, SYK, BSX, MDT, BDX, EW, RMD, IDXX, DXCM, and ZBH

Should you be buying Intuitive Surgical stock or one of its competitors? The main competitors of Intuitive Surgical include Abbott Laboratories (ABT), Stryker (SYK), Boston Scientific (BSX), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), ResMed (RMD), IDEXX Laboratories (IDXX), DexCom (DXCM), and Zimmer Biomet (ZBH). These companies are all part of the "medical" sector.

Intuitive Surgical vs.

Abbott Laboratories (NYSE:ABT) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, community ranking, risk, profitability, valuation and earnings.

Abbott Laboratories has higher revenue and earnings than Intuitive Surgical. Abbott Laboratories is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abbott Laboratories$41.22B4.88$5.72B$3.2935.24
Intuitive Surgical$7.87B24.53$1.80B$6.2287.11

Intuitive Surgical has a net margin of 28.51% compared to Abbott Laboratories' net margin of 13.99%. Abbott Laboratories' return on equity of 20.18% beat Intuitive Surgical's return on equity.

Company Net Margins Return on Equity Return on Assets
Abbott Laboratories13.99% 20.18% 10.84%
Intuitive Surgical 28.51%13.41%11.83%

In the previous week, Intuitive Surgical had 1 more articles in the media than Abbott Laboratories. MarketBeat recorded 46 mentions for Intuitive Surgical and 45 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.50 beat Intuitive Surgical's score of 1.40 indicating that Abbott Laboratories is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Abbott Laboratories
42 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Intuitive Surgical
35 Very Positive mention(s)
4 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Abbott Laboratories has a beta of 0.72, indicating that its stock price is 28% less volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 1.39, indicating that its stock price is 39% more volatile than the S&P 500.

Intuitive Surgical received 104 more outperform votes than Abbott Laboratories when rated by MarketBeat users. However, 69.70% of users gave Abbott Laboratories an outperform vote while only 68.97% of users gave Intuitive Surgical an outperform vote.

CompanyUnderperformOutperform
Abbott LaboratoriesOutperform Votes
934
69.70%
Underperform Votes
406
30.30%
Intuitive SurgicalOutperform Votes
1038
68.97%
Underperform Votes
467
31.03%

Abbott Laboratories presently has a consensus target price of $130.07, indicating a potential upside of 12.19%. Intuitive Surgical has a consensus target price of $524.61, indicating a potential downside of 3.18%. Given Abbott Laboratories' stronger consensus rating and higher possible upside, research analysts plainly believe Abbott Laboratories is more favorable than Intuitive Surgical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Abbott Laboratories
0 Sell rating(s)
4 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.75
Intuitive Surgical
1 Sell rating(s)
4 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.68

75.2% of Abbott Laboratories shares are held by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are held by institutional investors. 0.5% of Abbott Laboratories shares are held by insiders. Comparatively, 0.8% of Intuitive Surgical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Intuitive Surgical beats Abbott Laboratories on 11 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ISRG vs. The Competition

MetricIntuitive SurgicalSurgical appliances & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$192.98B$9.70B$5.06B$8.82B
Dividend YieldN/A1.10%5.18%4.07%
P/E Ratio87.1123.02126.3117.81
Price / Sales24.5330.911,178.7474.57
Price / Cash97.2823.3733.8632.53
Price / Book14.255.614.684.68
Net Income$1.80B$182.72M$119.54M$226.08M
7 Day Performance0.75%38.40%-1.83%-1.04%
1 Month Performance4.43%54.60%-3.60%1.04%
1 Year Performance73.76%3.49%31.91%26.28%

Intuitive Surgical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ISRG
Intuitive Surgical
4.653 of 5 stars
$541.82
+0.6%
$524.61
-3.2%
+74.0%$191.92B$7.12B87.1113,676Analyst Upgrade
Positive News
ABT
Abbott Laboratories
4.9683 of 5 stars
$115.93
-1.0%
$130.07
+12.2%
+14.6%$201.08B$41.22B35.24114,000Positive News
SYK
Stryker
4.9396 of 5 stars
$385.68
-0.8%
$393.65
+2.1%
+33.3%$148.17B$20.50B41.3452,000Analyst Revision
Positive News
BSX
Boston Scientific
4.5971 of 5 stars
$90.17
-0.2%
$93.39
+3.6%
+65.6%$132.90B$14.24B74.5248,000Analyst Forecast
MDT
Medtronic
4.9582 of 5 stars
$84.11
-1.0%
$95.19
+13.2%
+11.9%$109.01B$32.36B25.7295,000Earnings Report
Analyst Forecast
BDX
Becton, Dickinson and Company
4.9899 of 5 stars
$222.41
-0.1%
$283.00
+27.2%
-4.8%$64.35B$20.18B37.4473,000Positive News
EW
Edwards Lifesciences
4.1259 of 5 stars
$69.54
-0.9%
$75.67
+8.8%
+3.5%$41.40B$6.00B10.0319,800Short Interest ↓
Analyst Revision
RMD
ResMed
4.797 of 5 stars
$241.55
+1.4%
$225.70
-6.6%
+59.7%$34.96B$4.69B31.999,980Positive News
IDXX
IDEXX Laboratories
4.8654 of 5 stars
$418.61
+0.5%
$552.38
+32.0%
-11.5%$34.09B$3.66B40.3711,000Positive News
DXCM
DexCom
4.9834 of 5 stars
$75.24
+0.5%
$104.59
+39.0%
-30.9%$29.25B$3.95B45.059,600
ZBH
Zimmer Biomet
4.6279 of 5 stars
$109.31
-1.5%
$123.22
+12.7%
-2.8%$22.09B$7.39B20.7818,000Positive News

Related Companies and Tools


This page (NASDAQ:ISRG) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners